Eargo Revenue and Competitors

Location

$217.2M

Total Funding

Estimated Revenue & Valuation

  • Eargo's estimated annual revenue is currently $85.5M per year.(i)
  • Eargo received $52.0M in venture funding in March 2019.
  • Eargo's estimated revenue per employee is $348,980
  • Eargo's total funding is $217.2M.
  • Eargo's current valuation is $216.3M. (January 2022)

Employee Data

  • Eargo has 245 Employees.(i)
  • Eargo grew their employee count by -21% last year.

Eargo's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
CFOReveal Email/Phone
3
SVP & Chief Accounting OfficerReveal Email/Phone
4
VP Advanced Development Systems and Hardware EngineeringReveal Email/Phone
5
Head Product ManagementReveal Email/Phone
6
Associate General Counsel and Chief Compliance OfficerReveal Email/Phone
7
Head RetailReveal Email/Phone
8
VP, Field SalesReveal Email/Phone
9
VP People OperationsReveal Email/Phone
10
VP, Strategic Reimbursement and AccessReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$6.6M54-47%$31MN/A
#2
$185.9M65522%N/AN/A
#3
$346.1M1379-1%N/AN/A
#4
$13.9M6329%$77.7MN/A
#5
$2442.6M69721%$430.2KN/A
#6
$21.3M795%N/AN/A
#7
$192M5697%N/AN/A
#8
$48.6M1556%$318.8MN/A
Add Company

What Is Eargo?

We're Eargo. A company made up of ENT surgeons, tech geeks and dreamers, united in our belief that people should be able to hear life to the fullest. Because the world is full of great things to hear. And because, well, we really like people. It's because we like people that we do what we do. We want the best for them, and this is our way to make sure they get it (we also like pina coladas, cuddly puppies and long walks on the beach, in case you're wondering). We don't believe that caring for your hearing health should come at the cost of compromising your lifestyle or appearance. That's why we've created devices that work superbly, are easy to use and - because of our patented Flexi Fibers - are incredibly comfortable and essentially invisible. We start with the user, the person who's going to open the Eargo box with eager anticipation, and build all of our products and experiences in ways that make them feel understood and cared for. That pays off their eager anticipation. We feel that the best technology should be natural, not intrusive. That is should serve us, not the other way around. Through improving hearing, we want to help people live and feel better. Because, like we said before, we like people. Eargo is designed for mild to moderate hearing loss. Will not restore normal hearing. Full benefit best obtained with frequent use. Visit Eargo.com/guides for more information and labeling.

keywords:Healthcare,Medical Devices

$217.2M

Total Funding

245

Number of Employees

$85.5M

Revenue (est)

-21%

Employee Growth %

$216.3M

Valuation

N/A

Accelerator

Eargo News

2022-04-13 - Best Hearing Aids Reviewed: What are the Top Hearing Aids ...

The brand includes these models: Eargo 6, Eargo 5, Eargo Neo Hifi, and Eargo Max. HearAssist Pro, The hearing aid has amplifiers that intensify...

2022-04-13 - Best Hearing Aids That Work - Compare the Best Hearing Aid ...

Eargo Neo HiFI is also entirely in the canal type of hearing aid models and nearly invisible. Its batteries are rechargeable, making it one of...

2022-03-30 - Global Hearing Amplifiers Market Size, Share & Industry Trends Analysis Report By Product, By Type, By Distribution Channel, By Regional Outlook and Forecast, 2021 - 2027

Jan-2022: Eargo introduced Eargo 6, its sixth-generation FDA Class II exempt hearing aid and most powerful device. Eargo 6 features: Hearing...

2020-10-16 - Eargo goes public, raising $141.3M

San Jose, Calif.-based Eargo makes small, rechargeable hearing aids that sit in the user’s ear canal, so others can’t see them. They sell for between $1,850 or $3,000 for a pair, depending on the model. Users control settings, such as whether they’re in a crowded room or on a phone call, throug ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$15M24518%N/A
#2
$38.3M2460%$62M
#3
$42.3M246-21%N/A
#4
N/A26210%N/A
#5
$37.9M26529%N/A

Eargo Funding

DateAmountRoundLead InvestorsReference
2015-06-26$13.6MAMaveronArticle
2015-12-10$25.0MBNEAArticle
2017-10-20$45.0MCNan Fung Life SciencesArticle
2019-03-06$52.0MDMulitpleArticle